tradingkey.logo

Kenvue falls ahead of Trump's 'important' announcement on autism findings

ReutersSep 22, 2025 1:56 PM

Shares of Tylenol maker Kenvue KVUE.N fall 4% to $17.61

U.S. President Donald Trump said on Saturday his administration would make announcement about its autism findings on Monday, declining to offer specifics

The Wall Street Journal reported earlier this month that Health Secretary Robert F. Kennedy Jr. plans to announce that use of KVUE's popular over-the-counter pain medication, Tylenol, by pregnant women is potentially linked to autism, contrary to medical guidelines that say it is safe to use

Kenvue has previously said it continues to believe that taking acetaminophen - the active ingredient in Tylenol - does not cause autism

Up to last close, stock down 14.1% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI